Press Release – New York, NY – February 8, 2021 – Sichenzia Ross Ference LLP announced today that it has represented Equillium, Inc. (NASDAQ:EQ) in a registered direct offering with life science …
Sichenzia Ross Ference LLP Represents Aegis Capital in $12.1 Million Follow-On Offering of BiondVax Pharmaceuticals Ltd. American Depositary Shares
Press Release – New York, NY – February 2, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 2,434,783 American …
Sichenzia Ross Ference LLP Represents High Tide Inc. in the $8.0 million acquisition of Smoke Cartel, Inc.
Press Release – New York, NY – January 25, 2021 – Sichenzia Ross Ference LLP announced today that its mergers and acquisitions team has represented High Tide Inc. (OTCQB:HITIF) in its acquisition of …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in Close of $11 Million Underwritten Public Offering and NASDAQ Uplisting
Press Release – New York, NY – January 14, 2021 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: “LEXX”), in a closing of an underwritten public …
Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering
Press Release – New York, New York – September 10, 2020 - Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and …
Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.2 Million Underwritten Public Offering of Avinger Inc. Common Stock
Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 11,063,830 …
